The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Gowen Maxine since year 2005.
The trader's CIK number is 1280044.
At the time of this reporting, Gowen Maxine is the President & CEO of Trevena Inc .
(stock ticker symbol TRVN).
See this page for all insider trading activities at Trevena Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-02-23||TRVN||Trevena Inc||Option Ex||110,403||.68||75,294|
|2014-11-13||AKBA||Akebia Therapeutics, Inc.||Buy||1,300||11.82||15,364|
|2014-04-23||TRVN||Trevena Inc||Option Ex||124,477||.68||84,893|
|2011-03-21||HGSI||Human Genome Sciences Inc||Sale||7,926||27.29||216,292|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gowen Maxine (President & CEO of Trevena Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.